ArticleFrontiers in pharmacology2024

Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database.

Wenwen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.